Page last updated: 2024-09-04

platycodin d and Cancer of Prostate

platycodin d has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, J; Liu, J; Liu, K; Lu, Z; Mi, M; Xu, H; Yang, J; Zhou, R; Zhou, Y	1

Other Studies

1 other study(ies) available for platycodin d and Cancer of Prostate

Article	Year
Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo. Current cancer drug targets, 2015, Volume: 14, Issue:9 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Mice, Nude; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Random Allocation; Recombinant Proteins; Resting Phase, Cell Cycle; Saponins; Specific Pathogen-Free Organisms; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays	2015

Article

Year

Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.

Current cancer drug targets, 2015, Volume: 14, Issue:9

Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Mice, Nude; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Random Allocation; Recombinant Proteins; Resting Phase, Cell Cycle; Saponins; Specific Pathogen-Free Organisms; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays

2015